203940-51-6

Basic information

• Product Name: methyl 4-({[2-(4-chlorophenylsulfonylamino)-1-(3-formylphenyl)ethyl]thio}methyl)benzoate
• Synonyms: methyl 4-({[2-(4-chlorophenylsulfonylamino)-1-(3-formylphenyl)ethyl]thio}methyl)benzoate
• CAS NO: 203940-51-6
• Molecular Weight: 504.027
• Mol File: 203940-51-6.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: methyl 4-({[2-(4-chlorophenylsulfonylamino)-1-(3-formylphenyl)ethyl]thio}methyl)benzoate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 4-({[2-(4-chlorophenylsulfonylamino)-1-(3-formylphenyl)ethyl]thio}methyl)benzoate(203940-51-6)
• EPA Substance Registry System: methyl 4-({[2-(4-chlorophenylsulfonylamino)-1-(3-formylphenyl)ethyl]thio}methyl)benzoate(203940-51-6)

Safety Data

• Hazardous Substances Data: 203940-51-6(Hazardous Substances Data)

Upstream product

• 203940-53-8 methyl 4-[({1-[3-(1,3-dioxolan-2-yl)phenyl]-2-nitroethyl}thio)methyl]benzoate 
• 203940-54-9 methyl 4-[({2-amino-1-[3-(1,3-dioxolan-2-yl)phenyl]ethyl}thio)methyl]benzoate 
• 203940-55-0 methyl 4-[({2-(4-chlorophenylsulfonylamino)-1-[3-(1,3-dioxolan-2-yl)phenyl]ethyl}thio)methyl]benzoate 
• 68348-23-2 3-(1,3-dioxolan-2-yl)benzaldehyde 
• 17789-14-9 3-(1,3-dioxolan-2-yl)-phenylbromide 
• 140639-94-7 2-(3'-hydroxymethyl)phenyl-1,3-dioxolane 
• 2417-72-3 Methyl 4-(bromomethyl)benzoate 
• 52010-98-7 3-(hydroxymethyl)benzaldehyde 
• 209688-43-7 4-methoxyformylbenzyl thioacetate 
• 922525-34-6 C₁₂H₁₇NO 
• 102203-61-2 4-Methoxycarbonylphenylmethanethiol 
• 203940-48-1 methyl 4-({[1-(3-hydroxymethylphenyl)-2-nitroethyl]thio}methyl)benzoate 
• 203940-50-5 methyl 4-({[2-(4-chlorophenylsulfonylamino)-1-(3-hydroxymethylphenyl)ethyl]thio}methyl)benzoate 

Downstream Products

• 203940-25-4 (+/-)-methyl 4-{[(2-{4-chlorophenylsulfonylamino}-1-{3-[(E)-2-(7-chloro-2-quinolyl)vinyl]phenyl}ethyl)thio]methyl}benzoate 

Relevant articles and documents

Synthesis of optically active thromboxane A2 and Leukotriene D4 receptor antagonists

Both (+)- and (-)-4-{[(2-{4-cUorophenylsulfonylamino}-1-{3-[(Q-2-(7-cWoro- 2-quinolyl)-vinyl]phenyl}ethyl)-thio]methyl}benzoic acid (1), Thromboxane A2 and Leukotriene D4 receptor dual antagonist were synthesized. Racemic methyl 4-({[2-amino-1-(3-hydroxym